Discover 3,590 paid clinical trials in Pasadena, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,590
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Los Angeles CA, Lubbock TX, Omaha NE, The Woodlands TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
for
Advanced Pheochromocytoma and Paraganglioma, PCPG
Location: Los Angeles CA, Palo Alto CA, Salt Lake City UT,
Location: Beverly Hills CA, Encino CA, Fullerton CA, Torrance CA,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung Cancer
for
Non Small Cell Lung Cancer, Lung Cancer
Location: Los Angeles CA, Beverly Hills CA, Torrance CA
Sponsor: Karen Reckamp, MD, MS
Sex: All
Age: 18+
Code: NCT05401110
Phase 1, Recruiting
Belatacept in Heart Transplantation
for
Heart Transplant
Location: Los Angeles CA, Salt Lake City UT, Kansas City MO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18 - 70+
Code: NCT06478017
Phase 2, Recruiting
Esophageal Temperature During PVI Using Q-DOT Micro
for
Atrial Fibrillation Paroxysmal
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT06392932
Recruiting
Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study
for
Shoulder Disease, Shoulder Injuries
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT06016257
Recruiting
Donidalorsen Treatment in Children With Hereditary Angioedema
for
Hereditary Angioedema (HAE)
Location: Santa Monica CA, Cincinnati OH, St Louis MO,
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All
Age: 2 - 11
Code: NCT07298447
Phase 3, Recruiting
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
for
Single Gene NIPT
Location: Los Angeles CA, San Carlos CA, Glendale AZ,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT06808880
Recruiting
A Phase I First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WGI-0301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Whittier CA, Los Angeles CA, Baltimore MD
Sponsor: Zhejiang Haichang Biotech Co., Ltd.
Sex: All
Age: 18+
Code: NCT05267899
Phase 1, Recruiting
Virtual Reality for ICU Delirium Prevention
for
ICU Delirium
Location: Los Angeles CA
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT07357389
Recruiting
KRT-232 in Combination With TL-895 for the Treatment of R/R MF and KRT-232 for the Treatment of JAKi Intolerant MF
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Whittier CA, Urbana IL, Birmingham AL, Lake City FL,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT04640532
Phase 1, Phase 2, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Fullerton CA, Long Beach CA, Denver CO, Laredo TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Standard of Care in Participants With Relapsed-Refractory Multiple Myeloma (RRMM)
for
Multiple Myeloma
Location: Whittier CA, Los Alamitos CA, Torrance CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07227311
Phase 2, Recruiting
Immune Tolerance Induction After Liver Transplantation